Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy.

World J Surg Oncol · 2025 · PMC11787757 · PMID 39893475

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

approaching borderline significanceP = 0.098so close (0.05 < p ≤ 0.1)

Moreover, stage IV was related to an early occurrence of the SCLC phenotype, approaching borderline significance (HR, 1.78; 95% CI, 0.90 to 3.52; P = 0.098).

also in 18 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.